These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5369679)

  • 21. Rationale for the use of alternating non-cross-resistant chemotherapy.
    Goldie JH; Coldman AJ; Gudauskas GA
    Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental affinity chemotherapy in cancer].
    Chen GJ; Wang SZ
    Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):154-9. PubMed ID: 2431479
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug activity and therapeutic synergism in cancer treatment.
    Carter WH; Wampler GL; Stablein DM; Campbell ED
    Cancer Res; 1982 Aug; 42(8):2963-71. PubMed ID: 6807534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingomyelin potentiates chemotherapy of human cancer xenografts.
    Modrak DE; Lew W; Goldenberg DM; Blumenthal R
    Biochem Biophys Res Commun; 2000 Feb; 268(2):603-6. PubMed ID: 10679250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2.
    Fu LW; He LR; Liang YJ; Chen LM; Xiong HY; Yang XP; Pan QC
    Yao Xue Xue Bao; 2003 Aug; 38(8):565-70. PubMed ID: 14628443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicine. Building better mouse models for studying cancer.
    Marx J
    Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of results of animal experiments in clinical tumor chemotherapy].
    Sugár J; Somfai-Relle Z; Németh L
    Orv Hetil; 1980 Jul; 121(29):1745-52. PubMed ID: 7454286
    [No Abstract]   [Full Text] [Related]  

  • 30. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical concepts derived from animal chemotherapy studies.
    Goldin A; Schabel FM
    Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined radiation therapy and chemotherapy for carcinoma of the cervix.
    Rose PG; Eifel PJ
    Cancer J; 2001; 7(2):86-94. PubMed ID: 11324770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Theoretical and experimental bases for the polychemotherapy of cancer].
    Delobel J; Mawas C; Israel L
    Poumon Coeur; 1968; 24(1):5-8. PubMed ID: 5652207
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemistry and bioassay of Zitostop.
    Vargha L; Baló J
    Ther Hung; 1971; 19(1):10-1. PubMed ID: 5093537
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

  • 38. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further studies on chemotherapy of experimental brain tumors.
    Shapiro WR
    Neurology; 1970 Apr; 20(4):390-1. PubMed ID: 5535017
    [No Abstract]   [Full Text] [Related]  

  • 40. Resectable VX-2 rabbit brain tumor model for development of intraoperative local administration of drugs.
    Ahmad F; Pacholska A; Tuppurainen V; Ylä-Herttuala S; Hyvärinen A
    Acta Neurochir (Wien); 2011 Oct; 153(10):1979-81. PubMed ID: 21681637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.